U.S. flag

An official website of the United States government

NM_004985.5(KRAS):c.451-5622G>A AND not provided

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Feb 13, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000590191.1

Allele description [Variation Report for NM_004985.5(KRAS):c.451-5622G>A]

NM_004985.5(KRAS):c.451-5622G>A

Gene:
KRAS:KRAS proto-oncogene, GTPase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12p12.1
Genomic location:
Preferred name:
NM_004985.5(KRAS):c.451-5622G>A
HGVS:
  • NC_000012.12:g.25215533C>T
  • NG_007524.1:g.40388G>A
  • NG_007524.2:g.40471G>A
  • NM_001369786.1:c.478G>A
  • NM_001369787.1:c.451-5622G>A
  • NM_004985.5:c.451-5622G>AMANE SELECT
  • NM_033360.4:c.478G>A
  • NP_001356715.1:p.Val160Met
  • NP_203524.1:p.Val160Met
  • LRG_344t1:c.451-5622G>A
  • LRG_344t2:c.478G>A
  • LRG_344:g.40471G>A
  • LRG_344p2:p.Val160Met
  • NC_000012.11:g.25368467C>T
  • NM_033360.2:c.478G>A
Protein change:
V160M
Links:
dbSNP: rs755877953
NCBI 1000 Genomes Browser:
rs755877953
Molecular consequence:
  • NM_001369787.1:c.451-5622G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_004985.5:c.451-5622G>A - intron variant - [Sequence Ontology: SO:0001627]
  • NM_001369786.1:c.478G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_033360.4:c.478G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: CN517202

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000699773Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Feb 13, 2017)
germlineclinical testing

LabCorp Variant Classification Summary - May 2015.docx

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000699773.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Variant summary: The KRAS c.478G>A (p.Val160Met) variant located in the P-loop containing nucleoside triphosphate hydrolase domain (via InterPro) involves the alteration of a conserved nucleotide, which 3/4 in silico tools (SNPs&GO not captured due to low reliability index) predict a damaging outcome, although these predictions have yet to be functionally assessed. The variant of interest was observed in the large, broad control population, ExAC, with an allele frequency of 1/121284 control chromosomes, which does not exceed the estimated maximal expected allele frequency for a pathogenic KRAS variant of 1/80000. The variant of interest has not, to our knowledge, been reported in affected individuals via publications and/or reputable databases/clinical diagnostic laboratories. Because of the absence of clinical information and the lack of functional studies, the variant of interest has been classified as a "Variant of Uncertain Significance (VUS)," until additional information becomes available.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 15, 2022